Management of histologic LSIL (CIN 1) preceded by ASC-H cytology

This algorithm describes management of histologic LSIL (CIN 1) preceded by ASC-H cytology.

LSIL: low-grade squamous intraepithelial lesion; CIN: cervical intraepithelial neoplasia; ASC-H: atypical squamous cells cannot exclude HSIL; HPV: human papillomavirus; HSIL: high-grade squamous intraepithelial lesion; ASCCP: American Society for Colposcopy and Cervical Pathology.
* Only if colposcopy visualizes the entire squamocolumnar junction and upper limit of lesion(s), and endocervical sampling negative.
¶ Except in pregnant women.

From: Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020; 24:102. DOI: 10.1097/LGT.0000000000000525. Copyright © 2020 the American Society for Colposcopy and Cervical Pathology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.

Graphic 127910 Version 1.0